Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.

[1]  C. Page,et al.  Suppression of Paf-acether responses: An anti-inflammatory effect of anti-asthma drugs , 1985, Agents and Actions.

[2]  K. Chung,et al.  Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. , 1987, Journal of applied physiology.

[3]  J. Price,et al.  Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma. , 1987, The Journal of allergy and clinical immunology.

[4]  K. Chung,et al.  EFFECT OF A GINKGOLIDE MIXTURE (BN 52063) IN ANTAGONISING SKIN AND PLATELET RESPONSES TO PLATELET ACTIVATING FACTOR IN MAN , 1987, The Lancet.

[5]  A. Wardlaw,et al.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.

[6]  T. Takishima,et al.  Protective effects of ketotifen on allergen‐induced bronchoconstriction and skin weal , 1986, Clinical allergy.

[7]  S. Holgate,et al.  The effect of inhaled 5-hydroxytryptamine (5-HT, serotonin) on airway calibre in man. , 1986, British journal of clinical pharmacology.

[8]  F. Cuss,et al.  EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MAN , 1986, The Lancet.

[9]  K. Chung,et al.  Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. , 1986, The Journal of pharmacology and experimental therapeutics.

[10]  G. Lilja,et al.  Ketotifen in pollen‐induced asthma: a double blind placebo‐controlled study , 1986, Clinical allergy.

[11]  J. Price,et al.  Effects of Ketotifen on in vitro bronchoconstriction , 1985, Clinical allergy.

[12]  A. Sheffer,et al.  A multicenter trial of the prophylactic effect of ketotifen, theophylline, and placebo in atopic asthma. , 1985, Journal of Allergy and Clinical Immunology.

[13]  G. Hedlin,et al.  The effect of ketotifen on bronchial hyperreactivity in childhood asthma. , 1985, The Journal of allergy and clinical immunology.

[14]  D. Macdonald,et al.  Effects of serum albumin, indomethacin and histamine H1‐antagonists on Paf‐acether‐induced inflammatory responses in the skin of experimental animals and man , 1985, British journal of pharmacology.

[15]  E. Cruz,et al.  Acute effect of ketotifen on the dose-response curve of histamine and methacholine in asthma. , 1985, British journal of diseases of the chest.

[16]  J. Martin,et al.  A comparison of the effects of ketotifen and clemastine on cutaneous and airway reactivity to histamine and allergen in atopic asthmatic subjects. , 1984, The Journal of allergy and clinical immunology.

[17]  B. Vargaftig,et al.  The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene , 1984, British journal of pharmacology.

[18]  M. Adachi,et al.  A comparison of the inhibitory effects of ketotifen and disodium cromoglycate on bronchial responses to house dust, with special reference to the late asthmatic response. , 1984, Pharmatherapeutica.

[19]  C. Greenwood.  The pharmacology of ketotifen. , 1982, Chest.

[20]  J. Girard.  Ketotifen and bronchial hyperreactivity in asthmatic patients , 1981, Clinical allergy.

[21]  P. Barnes,et al.  Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.

[22]  L. Craps.  Ketotifen in the oral prophylaxis of bronchial asthma: a review. , 1981, Pharmatherapeutica.

[23]  C. W. Clarke,et al.  A comparison of the efficacy of ketotifen (HC 20-511) with sodium cromoglycate (SCG) in skin test positive asthma. , 1980, British journal of clinical pharmacology.

[24]  D. Lane.  A steroid sparing effect of ketotifen in steroid‐dependent asthmatics , 1980, Clinical allergy.

[25]  H. Neijens,et al.  The correlation between increased reactivity of the bronchi and of mediator releasing cells in asthma , 1980, Clinical allergy.

[26]  W. Maclay,et al.  Endocrine aspects of liver disease. , 1980, British medical journal.

[27]  R. Hurme,et al.  A controlled study on the preventive effect of ketotifen, an antiallergic agent, on methacholine‐induced bronchoconstriction in asthmatics , 1979, Clinical allergy.

[28]  K. Mattson,et al.  Preventive effect of ketotifen, a new antiallergic agent, on histamine‐induced bronchoconstriction in asthmatics , 1979, Clinical allergy.